Posted On: 11/03/2014 11:57:48 AM
Post# of 72750
$BIIB Recent Headlines
AT&T, Yelp shares decline after earnings 5:48 p.m. Oct. 22, 2014 - Sue Chang
U.S. stocks wither; S&P 500 ends 4-day win steak 4:39 p.m. Oct. 22, 2014 - Carla Mozee
Updates, advisories and surprises 4:31 p.m. Oct. 22, 2014 - MarketWatch
Biogen shares drop on Tecfidera patient death 11:48 a.m. Oct. 22, 2014 - Russ Britt
Icahn says buying Apple is a ‘no-brainer’, and a first-ever for the VIX 11:37 a.m. Oct. 22, 2014 - Barbara Kollmeyer
Biogen Idec shares slump 7.6% 9:32 a.m. Oct. 22, 2014 - Sue Chang
Biogen shares turn lower; analyst says key MS drug sales missed expectations 8:37 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen shares turn lower, down 2.7% premarket after Q3 results 8:13 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen beats estimates on strong MS drug sales 7:49 a.m. Oct. 22, 2014 - MarketWatch.com
Biogen shares rally after beating profit expectations, raising outlook 7:15 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen shares gain 0.7% premarket after Q3 results 7:06 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen ups full-year adj. EPS outlook to $13.45-$13.55 vs. FactSet estimate $13.10 7:05 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen Q3 net EPS $3.62 vs. $2.05 a year ago 7:03 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen Q3 FactSet sales consensus $2.48 bln 7:03 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen Q3 sales $2.51 bln vs. $1.83 bln a year ago 7:03 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen Q3 adj. EPS $3.80 vs. FactSet consensus $3.45 7:02 a.m. Oct. 22, 2014 - Tomi Kilgore
Boeing, AT&T reports due Wednesday; Yahoo up late 6:48 p.m. Oct. 21, 2014 - Sue Chang
More than 1/3 of Dow stocks to report this week 5:30 a.m. Oct. 19, 2014 - Wallace Witkowski
NYSE to expand number of companies on biotech index 5:52 p.m. Oct. 14, 2014 - Wallace Witkowski
14 stocks loved by top-performing fund managers 6:49 a.m. Sept. 18, 2014 - Philip van Doorn
20 Stocks That Could Beat the Market in November 9:50 a.m. Today - TheStreet.com
Alkermes Incurs Wider Q3 Loss but Revenues Grow Y/Y - Analyst Blog 4:30 p.m. Oct. 31, 2014 - Zacks.com
Affymetrix Beats Q3 Earnings & Revenues; Raises '14 View - Analyst Blog 3:30 p.m. Oct. 31, 2014 - Zacks.com
Incyte Gains on Q3 Earnings and Revenue Beat, Raises View - Analyst Blog 1:49 p.m. Oct. 31, 2014 - Zacks.com
Acorda (ACOR) Beats on Q3 Earnings, Ups Ampyra Outlook - Analyst Blog 1:20 p.m. Oct. 31, 2014 - Zacks.com
AMAG Up on Q3 Earnings Beat, Revenues Up - Analyst Blog 10:57 a.m. Oct. 31, 2014 - Zacks.com
Today's Momo Momentum Stock To Watch: Biogen Idec (BIIB) 9:50 a.m. Oct. 31, 2014 - TheStreet.com
Incyte (INCY) Looks Good: Stock Moves 10.9% Higher - Tale of the Tape 9:46 a.m. Oct. 31, 2014 - Zacks.com
BIND Therapeutics, Inc. (BIND) Surges: Stock Rises 14.2% Higher - Tale of the Tape 9:11 a.m. Oct. 31, 2014 - Zacks.com
Jim Cramer's Top Stock Picks: CELG REGN GILD BIIB TTWO CRL FLEX 6:00 a.m. Oct. 31, 2014 - TheStreet.com
Cramer's Mad Money - Charles River Labs Battles Ebola (10/30/14) 5:46 a.m. Oct. 31, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Here's Why the Bears Were Dead Wrong 8:11 p.m. Oct. 30, 2014 - TheStreet.com
Qiagen Q3 Earnings, Revenues in Line; Outlook Revised - Analyst Blog 2:50 p.m. Oct. 30, 2014 - Zacks.com
Oncolytics Biotech (ONCY) Looks Good: Stock Soars 26% - Tale of the Tape 9:25 a.m. Oct. 30, 2014 - Zacks.com
Buy These Top Ranked ETFs on Solid Biotech Stock Earnings - ETF News And Commentary 8:00 a.m. Oct. 30, 2014 - Zacks.com
Amgen Up on Strategic Initiatives and 2015 Guidance - Analyst Blog 3:05 p.m. Oct. 29, 2014 - Zacks.com
Ligand Pharmaceuticals' Shares Fall on Q3 Earnings Miss - Analyst Blog 2:00 p.m. Oct. 29, 2014 - Zacks.com
Vertex Pharmaceuticals Posts Narrower-than-Expected Loss - Analyst Blog 1:00 p.m. Oct. 29, 2014 - Zacks.com
Biotech Stock Roundup: Beat & Raise Quarter for Amgen, Celgene, Alexion, Biogen - Analyst Blog 12:28 p.m. Oct. 29, 2014 - Zacks.com
One More Time: The Genzyme Contingent Value Right 10:15 a.m. Oct. 29, 2014 - Seeking Alpha
3D Bioprinting Technology Developed by RBCC Partner n3D Biosciences Helps Researchers Create a Better In Vitro Breast Cancer Model 5:30 a.m. Today - BusinessWire - BZX
Biogen Idec and Sobi announce European Medicines Agency validates Elocta(TM) (rFVIIIFc) Marketing Authorisation Application for review 4:10 p.m. Oct. 31, 2014 - Thomson Reuters ONE
Biogen Idec and Sobi Announce European Medicines Agency Validates ELOCTA™ (rFVIIIFc) Marketing Authorization Application for Review 4:05 p.m. Oct. 31, 2014 - BusinessWire - BZX
Quarterly Earnings Releases, Technical Updates, Software Launches, Welfare Initiatives, and New Health Plans - Research Reports on Biogen, Express Scripts, Covidien, Alexion and Aetna 8:45 a.m. Oct. 30, 2014 - PR Newswire - PRF
Market Movers - Biotech Stocks -- NewLink Genetics, Biogen Idec, United Therapeutics, Dynavax Technologies, and Amarin 8:40 a.m. Oct. 29, 2014 - PR Newswire - PRF
Leading Researchers Join Biogen Idec to Advance Drug Discovery for Neurodegenerative Diseases 7:30 a.m. Oct. 23, 2014 - BusinessWire - BZX
Regulatory Approval, Customer Safety Alert, Patient Support Program Launch, Earnings Releases, and Rating - Research Reports on Medtronic, Covidien, Biogen Idec, Baxter and Express Scripts 8:55 a.m. Oct. 21, 2014 - PR Newswire - PRF
Biogen Idec and Gretchen Rubin Unveil MS BlueprintTM, a New Online Tool to Help People with Multiple Sclerosis Attain Personal Goals 8:01 a.m. Oct. 15, 2014 - BusinessWire - BZX
Presentation of Clinical Data, FDA Approval, Notes Offering, and Market Activity - Research Reports on Biogen Idec, Arrowhead, Salix, HCA and Shire 8:30 a.m. Oct. 13, 2014 - PR Newswire - PRF
Sobi's collaboration partner Biogen Idec files marketing authorisation application for Elocta(TM) (rFVIIIFc) in Europe 3:01 p.m. Oct. 9, 2014 - Thomson Reuters ONE
CORRECTING and REPLACING Biogen Idec To Report Third Quarter 2014 Financial Results on October 22, 2014 4:01 p.m. Oct. 8, 2014 - BusinessWire - BZX
Earnings Release Schedules, Data Presentation, Regulatory Approvals, and Strategic Collaboration - Research Reports on Covidien, Biogen, Amgen, Agios and Baxter 8:55 a.m. Oct. 1, 2014 - PR Newswire - PRF
Biogen Idec To Report Third Quarter 2014 Financial Results on October 22, 2014 5:34 p.m. Sept. 25, 2014 - BusinessWire - BZX
Results of Clinical Trials, New Drug Applications, Leadership Appointments, and Scheduled Earnings - Research Reports on Biogen, Salix, Express Scripts, Stryker and Shire 9:25 a.m. Sept. 23, 2014 - PR Newswire - PRF
Biogen Idec Named Global Biotechnology Industry Leader on Dow Jones Sustainability World Index 8:00 a.m. Sept. 23, 2014 - BusinessWire - BZX
Olivier Danos Joins Biogen Idec as Senior Vice President, Gene Therapy 7:00 a.m. Sept. 23, 2014 - BusinessWire - BZX
Sobi expands Haemophilia development portfolio - elects to include potentially longer-acting Haemophilia A candidate in collaboration agreement with Biogen Idec 2:01 a.m. Sept. 19, 2014 - Thomson Reuters ONE
Ignyta to Participate in Precision Medicine Panel Discussions with Other Thought Leaders 7:00 a.m. Sept. 17, 2014 - BusinessWire - BZX
Event Schedules, Survey Findings, Regulatory Filings, and Market Activity - Research Reports on Amgen, Biogen Idec, Salix, Covidien and Shire 8:50 a.m. Sept. 15, 2014 - PR Newswire - PRF
Health Care Sector Stocks Technical Review - Ampio Pharma, InterMune, Biogen Idec, Hologic, and CareFusion Corp. 8:40 a.m. Sept. 15, 2014 - PR Newswire - PRF
AT&T, Yelp shares decline after earnings 5:48 p.m. Oct. 22, 2014 - Sue Chang
U.S. stocks wither; S&P 500 ends 4-day win steak 4:39 p.m. Oct. 22, 2014 - Carla Mozee
Updates, advisories and surprises 4:31 p.m. Oct. 22, 2014 - MarketWatch
Biogen shares drop on Tecfidera patient death 11:48 a.m. Oct. 22, 2014 - Russ Britt
Icahn says buying Apple is a ‘no-brainer’, and a first-ever for the VIX 11:37 a.m. Oct. 22, 2014 - Barbara Kollmeyer
Biogen Idec shares slump 7.6% 9:32 a.m. Oct. 22, 2014 - Sue Chang
Biogen shares turn lower; analyst says key MS drug sales missed expectations 8:37 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen shares turn lower, down 2.7% premarket after Q3 results 8:13 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen beats estimates on strong MS drug sales 7:49 a.m. Oct. 22, 2014 - MarketWatch.com
Biogen shares rally after beating profit expectations, raising outlook 7:15 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen shares gain 0.7% premarket after Q3 results 7:06 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen ups full-year adj. EPS outlook to $13.45-$13.55 vs. FactSet estimate $13.10 7:05 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen Q3 net EPS $3.62 vs. $2.05 a year ago 7:03 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen Q3 FactSet sales consensus $2.48 bln 7:03 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen Q3 sales $2.51 bln vs. $1.83 bln a year ago 7:03 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen Q3 adj. EPS $3.80 vs. FactSet consensus $3.45 7:02 a.m. Oct. 22, 2014 - Tomi Kilgore
Boeing, AT&T reports due Wednesday; Yahoo up late 6:48 p.m. Oct. 21, 2014 - Sue Chang
More than 1/3 of Dow stocks to report this week 5:30 a.m. Oct. 19, 2014 - Wallace Witkowski
NYSE to expand number of companies on biotech index 5:52 p.m. Oct. 14, 2014 - Wallace Witkowski
14 stocks loved by top-performing fund managers 6:49 a.m. Sept. 18, 2014 - Philip van Doorn
20 Stocks That Could Beat the Market in November 9:50 a.m. Today - TheStreet.com
Alkermes Incurs Wider Q3 Loss but Revenues Grow Y/Y - Analyst Blog 4:30 p.m. Oct. 31, 2014 - Zacks.com
Affymetrix Beats Q3 Earnings & Revenues; Raises '14 View - Analyst Blog 3:30 p.m. Oct. 31, 2014 - Zacks.com
Incyte Gains on Q3 Earnings and Revenue Beat, Raises View - Analyst Blog 1:49 p.m. Oct. 31, 2014 - Zacks.com
Acorda (ACOR) Beats on Q3 Earnings, Ups Ampyra Outlook - Analyst Blog 1:20 p.m. Oct. 31, 2014 - Zacks.com
AMAG Up on Q3 Earnings Beat, Revenues Up - Analyst Blog 10:57 a.m. Oct. 31, 2014 - Zacks.com
Today's Momo Momentum Stock To Watch: Biogen Idec (BIIB) 9:50 a.m. Oct. 31, 2014 - TheStreet.com
Incyte (INCY) Looks Good: Stock Moves 10.9% Higher - Tale of the Tape 9:46 a.m. Oct. 31, 2014 - Zacks.com
BIND Therapeutics, Inc. (BIND) Surges: Stock Rises 14.2% Higher - Tale of the Tape 9:11 a.m. Oct. 31, 2014 - Zacks.com
Jim Cramer's Top Stock Picks: CELG REGN GILD BIIB TTWO CRL FLEX 6:00 a.m. Oct. 31, 2014 - TheStreet.com
Cramer's Mad Money - Charles River Labs Battles Ebola (10/30/14) 5:46 a.m. Oct. 31, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Here's Why the Bears Were Dead Wrong 8:11 p.m. Oct. 30, 2014 - TheStreet.com
Qiagen Q3 Earnings, Revenues in Line; Outlook Revised - Analyst Blog 2:50 p.m. Oct. 30, 2014 - Zacks.com
Oncolytics Biotech (ONCY) Looks Good: Stock Soars 26% - Tale of the Tape 9:25 a.m. Oct. 30, 2014 - Zacks.com
Buy These Top Ranked ETFs on Solid Biotech Stock Earnings - ETF News And Commentary 8:00 a.m. Oct. 30, 2014 - Zacks.com
Amgen Up on Strategic Initiatives and 2015 Guidance - Analyst Blog 3:05 p.m. Oct. 29, 2014 - Zacks.com
Ligand Pharmaceuticals' Shares Fall on Q3 Earnings Miss - Analyst Blog 2:00 p.m. Oct. 29, 2014 - Zacks.com
Vertex Pharmaceuticals Posts Narrower-than-Expected Loss - Analyst Blog 1:00 p.m. Oct. 29, 2014 - Zacks.com
Biotech Stock Roundup: Beat & Raise Quarter for Amgen, Celgene, Alexion, Biogen - Analyst Blog 12:28 p.m. Oct. 29, 2014 - Zacks.com
One More Time: The Genzyme Contingent Value Right 10:15 a.m. Oct. 29, 2014 - Seeking Alpha
3D Bioprinting Technology Developed by RBCC Partner n3D Biosciences Helps Researchers Create a Better In Vitro Breast Cancer Model 5:30 a.m. Today - BusinessWire - BZX
Biogen Idec and Sobi announce European Medicines Agency validates Elocta(TM) (rFVIIIFc) Marketing Authorisation Application for review 4:10 p.m. Oct. 31, 2014 - Thomson Reuters ONE
Biogen Idec and Sobi Announce European Medicines Agency Validates ELOCTA™ (rFVIIIFc) Marketing Authorization Application for Review 4:05 p.m. Oct. 31, 2014 - BusinessWire - BZX
Quarterly Earnings Releases, Technical Updates, Software Launches, Welfare Initiatives, and New Health Plans - Research Reports on Biogen, Express Scripts, Covidien, Alexion and Aetna 8:45 a.m. Oct. 30, 2014 - PR Newswire - PRF
Market Movers - Biotech Stocks -- NewLink Genetics, Biogen Idec, United Therapeutics, Dynavax Technologies, and Amarin 8:40 a.m. Oct. 29, 2014 - PR Newswire - PRF
Leading Researchers Join Biogen Idec to Advance Drug Discovery for Neurodegenerative Diseases 7:30 a.m. Oct. 23, 2014 - BusinessWire - BZX
Regulatory Approval, Customer Safety Alert, Patient Support Program Launch, Earnings Releases, and Rating - Research Reports on Medtronic, Covidien, Biogen Idec, Baxter and Express Scripts 8:55 a.m. Oct. 21, 2014 - PR Newswire - PRF
Biogen Idec and Gretchen Rubin Unveil MS BlueprintTM, a New Online Tool to Help People with Multiple Sclerosis Attain Personal Goals 8:01 a.m. Oct. 15, 2014 - BusinessWire - BZX
Presentation of Clinical Data, FDA Approval, Notes Offering, and Market Activity - Research Reports on Biogen Idec, Arrowhead, Salix, HCA and Shire 8:30 a.m. Oct. 13, 2014 - PR Newswire - PRF
Sobi's collaboration partner Biogen Idec files marketing authorisation application for Elocta(TM) (rFVIIIFc) in Europe 3:01 p.m. Oct. 9, 2014 - Thomson Reuters ONE
CORRECTING and REPLACING Biogen Idec To Report Third Quarter 2014 Financial Results on October 22, 2014 4:01 p.m. Oct. 8, 2014 - BusinessWire - BZX
Earnings Release Schedules, Data Presentation, Regulatory Approvals, and Strategic Collaboration - Research Reports on Covidien, Biogen, Amgen, Agios and Baxter 8:55 a.m. Oct. 1, 2014 - PR Newswire - PRF
Biogen Idec To Report Third Quarter 2014 Financial Results on October 22, 2014 5:34 p.m. Sept. 25, 2014 - BusinessWire - BZX
Results of Clinical Trials, New Drug Applications, Leadership Appointments, and Scheduled Earnings - Research Reports on Biogen, Salix, Express Scripts, Stryker and Shire 9:25 a.m. Sept. 23, 2014 - PR Newswire - PRF
Biogen Idec Named Global Biotechnology Industry Leader on Dow Jones Sustainability World Index 8:00 a.m. Sept. 23, 2014 - BusinessWire - BZX
Olivier Danos Joins Biogen Idec as Senior Vice President, Gene Therapy 7:00 a.m. Sept. 23, 2014 - BusinessWire - BZX
Sobi expands Haemophilia development portfolio - elects to include potentially longer-acting Haemophilia A candidate in collaboration agreement with Biogen Idec 2:01 a.m. Sept. 19, 2014 - Thomson Reuters ONE
Ignyta to Participate in Precision Medicine Panel Discussions with Other Thought Leaders 7:00 a.m. Sept. 17, 2014 - BusinessWire - BZX
Event Schedules, Survey Findings, Regulatory Filings, and Market Activity - Research Reports on Amgen, Biogen Idec, Salix, Covidien and Shire 8:50 a.m. Sept. 15, 2014 - PR Newswire - PRF
Health Care Sector Stocks Technical Review - Ampio Pharma, InterMune, Biogen Idec, Hologic, and CareFusion Corp. 8:40 a.m. Sept. 15, 2014 - PR Newswire - PRF
(0)
(0)
